Prognostic Significance of MGMT Promoter Methylation in Patients with Glioblastoma Undergoing Surgical Intervention: A Retrospective Study in Northeastern Iran
Journal Title: Middle East Journal of Cancer - Year 2018, Vol 9, Issue 3
Abstract
Background: The standard of care for glioblastoma is concurrent chemoradiotherapy and adjuvant chemotherapy with Temozolomide. In this trial, we have investigated the impact of MGMT promoter methylation on prognosis and benefit from Temozolomide based chemotherapy in a group of patients with glioblastoma in our region. Methods: This retrospective study included glioblastoma patients treated in our institute between 2006 and 2011. We used methylation specific PCR to detect methylation in the promoter region of the MGMT gene. The Kaplan-Meier technique was used to calculate overall survival from the time of diagnosis to the time of death. We utilized the log-rank test and Cox-regression model for univariate and multivariate analyses of potential prognostic factors. Results: There were 78 patient participants with a median age of 50 (range: 20 to 75) years and a male to female ratio of 56/22. All patients underwent minimal surgical resection which was considered as a biopsy. All patients received adjuvant radiotherapy with a median dose of 60 Gy (54-60 Gy) and 25 patients received concomitant Temozolomide. The MGMT promoter methylation was found in 19 (24.4%) patients and was relatively more frequent in men (28.6%) compared to women (13.6%; P=0.16).This genetic change was associated with a significantly higher 2-year survival in men (57.2%) compared to women (16.8%; P<0.001). Multivariate analysis indicated that male sex and MGMT promoter methylation were independently associated with more favorable prognosis. Conclusion: In our series, MGMT promoter methylation was a significant independent prognostic factor. The finding of sex as an independent prognostic factor would need further validation.
Authors and Affiliations
Kazem Anvari, Mehdi Seilanian Toussi, Hossein Ayatollahi, Gholamreza Bahadorkhan, Mohammadreza Ghavam Nasiri, Mitra Fazl Ersi
Keywords
Related Articles
- EP ID EP303062
- DOI -
- Views 79
- Downloads 0
Patients’ Experiences with the Degenerative Process of Cancer: A Content-analysis Study in Iran
Background: This study sought to provide a comprehensive understanding of cancer treatment refusal based on the experiences of patients, caregivers, and health care providers. Methods: In this qualitative research study,...
Association of Epstein-Barr virus with Esophageal Squamous Cell Carcinoma
Introduction: Esophageal squamous cell carcinoma is among the leading causes of cancer related deaths within gastrointestinal tumors. There is a growing body of evidence that shows an association between Epstein Barr vir...
Small Cell Carcinoma of the Ovary: Report of a Case with Unusual and Aggressive Presentation
Small cell carcinoma of the ovary is an aggressive malignant tumor with no standard treatment. Despite surgery, chemotherapy and radiation, this tumor has a poor prognosis with rapid progression. The authors report a cas...
Spontaneous Tumor Lysis Syndrome in Primitive Neuroectodermal Tumor
Tumor lysis syndrome is caused by the massive lysis of tumor cells. It frequently occurs in rapidly proliferating malignancies and less often after solid tumor treatment. Spontaneous tumor lysis syndrome is extremely rar...
PTEN and p53 Gene Expressions in Breast Cancer Specimens and their Clinicopathological Significance
Background: Breast cancer is the second leading cause of cancer death after lung cancer. Discovering molecular biomarkers is necessary for disease management that includes prognosis prediction and preventive treatment. T...